Monitoring residual solvents in pharmaceutical products using a portable pre-concentration GC-PID.
J Pharm Biomed Anal
; 249: 116327, 2024 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-39089199
ABSTRACT
Pharmaceutical manufacturing utilizes solvents at different stages of production. Some of the harmful solvent residuals may be retained in the final product; therefore, they need to be monitored for quality control and to meet the regulation requirement. Here, a novel method capable of rapidly analyzing residual solvents in pharmaceutical products was developed using a compact-portable gas chromatography with a photoionization detector (GC-PID). The method consists of modified Tedlar® bag sampling, online pre-concentration, separation of volatiles by miniaturized GC, and micro-PID detection. The method detection limits of selected residual solvents were in the range of 26.00 - 52.03â¯pg/mL which is much lower than the pharmaceutical compliance concentration limits. Limits of detection > 520â¯pg of analyte per grams of sample was also determined for the over-the-counter drugs. The method performance showed rapid speed (5â¯min), linear calibration (r2 < 0.99), and repeatable retention time (RSD < 0.4â¯%). Direct analysis of residual solvents in solid samples was conducted without the need for complex sample preparation. The method validation using over-the-counter pharmaceutical products yielded excellent accuracy (recovery > 91.2â¯%) and precision (RSD < 6.5â¯%) for the selected residual solvents, including 1,4-dioxane, benzene, chlorobenzene, cyclohexane, xylenes, and toluene. This portable and rapid method could be deployed during the pharmaceutical drug manufacturing processes for quality control.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Solvents
/
Limit of Detection
Language:
En
Journal:
J Pharm Biomed Anal
Year:
2024
Document type:
Article
Country of publication:
Reino Unido